title: The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).
abstract: The endogenous cannabinoid anandamide was identified as an agonist for the recombinant human VR1 (hVR1) by screening a large array of bioactive substances using a FLIPR-based calcium assay. Further electrophysiological studies showed that anandamide (10 or 100 microM) and capsaicin (1 microM) produced similar inward currents in hVR1 transfected, but not in parental, HEK293 cells. These currents were abolished by capsazepine (1 microM). In the FLIPR anandamide and capsaicin were full agonists at hVR1, with pEC(50) values of 5. 94+/-0.06 (n=5) and 7.13+/-0.11 (n=8) respectively. The response to anandamide was inhibited by capsazepine (pK(B) of 7.40+/-0.02, n=6), but not by the cannabinoid receptor antagonists AM630 or AM281. Furthermore, pretreatment with capsaicin desensitized the anandamide-induced calcium response and vice versa. In conclusion, this study has demonstrated for the first time that anandamide acts as a full agonist at the human VR1.
authors.affiliation: Neuroscience Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, U.K. Darren_2_Smart@sbphrd.com
authors.forename: D
authors.initials: D
authors.lastname: Smart
authors.forename: M J
authors.initials: MJ
authors.lastname: Gunthorpe
authors.forename: J C
authors.initials: JC
authors.lastname: Jerman
authors.forename: S
authors.initials: S
authors.lastname: Nasir
authors.forename: J
authors.initials: J
authors.lastname: Gray
authors.forename: A I
authors.initials: AI
authors.lastname: Muir
authors.forename: J K
authors.initials: JK
authors.lastname: Chambers
authors.forename: A D
authors.initials: AD
authors.lastname: Randall
authors.forename: J B
authors.initials: JB
authors.lastname: Davis
mesh_terms: D000577:Amides; D001095:Arachidonic Acids / Q000494:pharmacology*; D001667:Binding, Competitive / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism; D002186:Cannabinoids / Q000494:pharmacology*; D002211:Capsaicin / Q000494:pharmacology; D002460:Cell Line; D003001:Cloning, Molecular; D004594:Electrophysiology; D063388:Endocannabinoids; D004983:Ethanolamines; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010169:Palmitic Acids / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D053284:Polyunsaturated Alkamides; D011955:Receptors, Drug / Q000187:drug effects*; D011994:Recombinant Proteins / Q000737:chemistry; D050916:TRPV Cation Channels
chemical_list: D000577:Amides; D001095:Arachidonic Acids; D015220:Calcium Channels; D002186:Cannabinoids; D063388:Endocannabinoids; D004983:Ethanolamines; D010169:Palmitic Acids; D053284:Polyunsaturated Alkamides; D011955:Receptors, Drug; D011994:Recombinant Proteins; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; C088155:methanandamide; C005958:palmidrol; D002211:Capsaicin; D002118:Calcium; C078814:anandamide